Small Business Resources, Business Advice and Forms from AllBusiness.com

Harvard Scientific receives approval of its application to conduct clinical trials for its...

LAS VEGAS--(BUSINESS WIRE)--July 10, 1996--Harvard Scientific Corp., of Las Vegas, (OTC BB:HVSF), a biopharmaceutical company, announced Wednesday that it has received approval of its application to conduct its clinical trials for its treatment of male erectile dysfunction from the Food and Drug Administration

(FDA).

The Investigative New Drug (IND) application lays out the scope, magnitude, and objectives sought in providing evidence of the safety, effectiveness and long term effects of impotency treatment.

Harvard Scientific Corp. continues to develop collaborative arrangements with a number of pharmaceutical companies to distribute its product in significant markets throughout the world.

CONTACT: Harvard Scientific Corp., Las Vegas

Neal Armstrong, 702/796-1173

In addition, make sure to read these articles: